Monoclonal antibodies (Mabs) were produced against outer-membrane proteins (OMPs) of Haemophilus infuenzae type b. The clones were screened by ELISA with outer-membrane preparations of H . inJuenzae type b and untypable strains as coating antigens. Antibodies directed against the proteins of mol. wt (lo3) 43, 37 and 13 were identified by immunoblotting of SDS-PAGE patterns of OMPs. Proteolytic enzyme treatments of the OMPs resulted in reduction of Mab reactivity as measured by ELISA. Furthermore, the absence of reactivity of Mab Hb-2 with a preparation of lipopolysaccharide confirmed the protein nature of its corresponding epitope. Binding assays with live bacteria showed that Hb-2 reacted with a cell surface-exposed antigenic determinant. Mab Hb-2 was bactericidal in vitro in the presence of complement. The characterisation of Hb-2 (IgG2,) by Western immunoblotting analysis revealed that it was directed against the 37 x 103-mol. wt OMP. In a dot-enzyme immunoassay, Hb-2 reacted specifically with 326 strains of H. inzuenzae type b. It did not cross-react with the other serotypes or untypable strains of H . infuenzae or with other bacterial species. This is the first report of a monoclonal antibody identifying a serotype-specific surface-exposed OMP of H . influenzae type b. H e inJluenzae type b OMPs have already been Eastern Ontario, Dr J. M. s. Dixon of the Provincial Laboratory described (Robertson et 1982 ; Gulig e f al.9 '983, of the Laboratoire de Santk Publique du Qukbec and Dr M Kh'lura et al.3 1985). In one case, 61.8% of the strains were identified by an antibody directed
Introduction
Haemophilus inzuenzae type b is the most common cause of meningitis in children under one year old. The recent emergence and rapid spread of antibiotic-resistant strains, particularly those resistant to ampicillin, are causing special problems in treatment (Philpott-Howard and Williams, 1982) . Chemoprophylaxis with rifampicin has given encouraging results by reducing the incidence of nasopharyngeal carriage (Daum and Glode, 1982) but such an approach has only limited application. Early treatment is essential to prevent complications. A reliable and rapid test is important for identification of the infectious agent after the antibiotic treatment has begun and when viable bacteria are no longer detectable in body fluids. Several immunoassays with polyclonal antisera have been adopted for bacterial antigen detection (Feldman, 1977 ; Thirumoorthi and Dajani, 1979) . They have all shown either poor specificity or sensitivity.
Outer-membrane proteins (OMPs) found on the cell surface of many gram-negative bacteria (McDade and Johnston, 1980; Hansen et al., 1981) have been used in serotyping (Zollinger et al., 1984; Frasch et al., 1985) and immunoprotection studies (Wang and Frasch, 1984; Brodeur et al., 1985 , Kimura et al., 1985 . The OMPs of H . infuenzae type b have received increasing interest as epidemiological markers (Loeb and Smith, 1980; Barenkamp et al., 1981 a and b) and as potential immunogens for young children (Gulig et al., 1984; Kimura et al., 1985) . Identification of a common surface antigen of H . infuenzae type b has been hampered by the antigenic variability of the OMPs (Erwin and Kenny, 1984) but the advent of monoclonal antibodies (Mabs) provides the opportunity to analyse the H . inJuenzae type b surface components with improved accuracy and reproducibility (Robertson et al., 1982; Gulig et al., 1983 and Kimura et al., 1985) .
In this paper, we report the generation of monoclonal antibodies directed against several OMPs of H . inzuenzae type b. One of these antibodies reacted with a surface component commqn to H . inzuenzae type b strains. The use of Mab I$b-2 for immunodiagnosis and serotyping of H . inzuenzae type b is discussed. 
Materials and methods

Bacterial strains and culture conditions
Outer membrane preparation
The extraction of outer membrane from the bacteria was performed as described by Johnston et al. (1976) with slight modifications (Brodeur et al., 1978) . Whole cells were suspended in lithium chloride buffer (200 mM lithium chloride, 100 mM lithium acetate, pH 6-0) and the bacteria were shaken with 6-mm glass beads at 300 rpm for 2 h at 45°C. The resulting spheroplasts were removed by centrifugation at 15 0009 for 20 min and the supernate was collected and centrifuged at 40 OOOg for 2 h. The pellet (OMP preparation) was washed once and then resuspended in phosphate-buffered saline (PBS). The protein content was determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Mississauga, Ontario, Canada).
Immunisation of mice
Balb/c mice were immunised by injections given intraperitoneally and into the foot pads. Each mouse received 50 pg of H. influenzae type b strain 3068 OMPs suspended in Freund's incomplete adjuvant (Gibco Laboratories, Grand Island, NY, USA). Four weeks later, the mice were given an intravenous injection of 30 pg of OMPs suspended in PBS. Another intravenous injection of 30pg of OMPs was given 4 days before hybridoma production. Sera were obtained from the immunised mice by cardiac puncture before the spleens were removed; these were the hyperimmune sera.
Fusion procedure
Hybridomas were produced by the methods of Fazekas De St Groth and Scheidegger (1980) with modifications (Brodeur et al. 1985) . Spleen cells from immunised mice and non-secreting, HGPRT-deficient, mouse myeloma cells (SP2/0) were fused in a ratio of 10: 1 in Dulbecco modified Eagle's medium (DMEM ; Flow Laboratories, Mississauga, Ontario, Canada) containing polyethylene glycol 1000 (T.J. Baker Chemical Co., Phillipsburg, NJ, USA) 50% w/v. The myeloma cells were cultured in the presence of 20 p~ 6-thioguanine for 5-7 days before the fusion. The fused cells (10' cellslml) were dispensed in 96-well tissue culture plates (Costar plastics, Vineland, NJ, USA), 0.1 ml per well, which already contained a feeder layer of 7 x lo3 murine peritoneal exudate cells per well. The cell suspensions were grown in DMEM supplemented with fetal calf serum (Gibco) 20% v/v, 2 mM L-glutamine (Sigma Chemical Co., St Louis, MO, USA) and gentamicin (Sigma) 50 pg/ml, in the presence of hypoxanthine, aminopterin and thymidine (HAT) as selective agents. On days 5 and 6 all cultures were checked for the presence of clones and the medium was changed on day 7, being replaced by HT instead of HAT. On days 10-12, supernates of wells containing growing clones were tested by ELISA for antibody directed against H. infruenzae type b outer-membrane antigens. The antibody-producing cells were subcloned by limiting dilution. Selected subclones were grown either in vitro for freezing in liquid nitrogen or as ascites according to the method of Brodeur et al. (1984) .
Determination of immunoglobulin class
The supernates from antibody-producing cells were tested against isotype-and subclass-specific antisera (Meloy, Springfield, VA, USA) by the Ouchterlony double diffusion method.
Enzyme-linked immunosorbent assay (ELISA) procedure
The screening of supernates for the presence of antibodies directed against H. infruenzae was performed as described by Brodeur et al. (1982) . A 0.1-ml volume of outer-membrane antigen containing 0.25 pg of protein in 0.05 M carbonate buffer, pH 9.6, was dispensed in each well of a Linbro E.I.A. microtitration plate (Flow). The plate was incubated for 18 h at room temperature to allow the adsorption of the antigen and then washed with PBS containing Tween 20 (Sigma) 0.02% v/v. A 0-2-ml volume of bovine serum albumin (BSA, Sigma) 0.1 % w/v in PBS was then added to each well. After incubating the plate for 30 min at 37"C, the BSA was discarded and the plate was washed and the test supernates were added. A standard serum was used as positive control. After incubation for 1 h at 37"C, the plate was washed thrice before the addition of 0.1 ml of alkaline phosphataseconjugated goat anti-mouse immunoglobulins (Miles Laboratories, Elkart, IN, USA) diluted 1 in 1000 in PBS containing BSA 3% w/v. After a further incubation for 1 h at 37"C, the plate was washed and 0.1 ml of diethanolamine solution 10% v/v, pH 9.8, containing pnitrophenylphosphate (Sigma) 1 mg/ml was added. After 60 min, the absorbance was determined spectrophotometrically at 410 nm with a Dynatech microplate reader MR 600. A reading >0.2 was scored as positive for the presence of antibodies directed against H. infuenzae type b outer-membrane antigens. Background level of absorbance with control SP2/0 myeloma cell culture supernate was always < 0-05.
Sodium dodecyl sulphate-polyacry lamide gel electrophoresis (SDS-PAGE)
OMPS were resolved by electrophoresis in 1-5 mmthick slab gels according to the method of Laemmli (1970) . The resolving gel and stacking gel contained 10% w/v and 4% w/v acrylamide (Bio-Rad) respectively. The samples were prepared by mixing one part of outermembrane antigens (1 mg of protein/ml) with four parts of the sample buffer (62.5 mM Tris-HCl, pH 6.8, glycerol 1% v/v, SDS 2% w/v, 2-mercaptoethanol 0.5% v/v and bromophenol blue 0.5% w/v) and heated for 4min at 100°C. Volumes of 80 pl containing 20-25 pg of protein were applied to each gel lane. Electrophoresis was performed at a constant current of 20 mA/gel until the bromophenol blue tracking dye entered the separating gel at which time the current was increased to 30 mA/ gel. The gels were stained with Coomassie blue dye and then destained as described by Weber and Osborn (1969) . The following proteins were used as mi.-wt (lo3) standards : myosin (200), phosphorylase b (92.5), bovine serum albumin (68), ovalbumin (43), a-chymotrypsinogen (25-7), P-lactoglobulin (18.4) and cytochrome C (12-3) (Bethesda Research Laboratories, BRL, Gaithersburg, MA, USA).
Immuno blo t t ing procedure
After SDS-PAGE, the proteins were transferred electrophoretically from the gel to nitrocellulose paper (Bio-Rad) by the method of Towbin et al. (1979) . A constant potential of 40 V (5 V/cm) was applied to the gel-nitrocellulose paper sandwich for 1.5 h in an electroblot buffer consisting of 25 mM Tris-HC 1,192 mM glycine and methanol 20% v/v, pH 8.3.
The transferred proteins on the blot were detected by autoradiography. The nitrocellulose paper was soaked for 30 rnin at room temperature in a solution of skimmed milk (Carnation) 5% w/v. The blot was incubated overnight at 4°C with mouse hyperimmune sera or ascitic AGAINST H . INFLUENZAE 165 fluid diluted in skimmed-milk solution and then washed for 10 rnin in PBS, followed by two more washes in PBS containing Nonidet P-40 0.05% v/v, and rinsed for 10 rnin in PBS. The blot was then soaked for 60 rnin at 37°C in skimmed-milk solution containing sheep anti-mouse immunoglobulins labelled with 251 (Amersham, Arlington Heights, IL, USA) 0.25 pCi/ml. After four washes as described above, the sheet was exposed for 24 h at -70°C to Kodak XAR-5 film in a Kodak X-omatic cassette fitted with intensifying screens.
Proteins transferred on to nitrocellulose paper were visualised by the biotin-avidin technique. Proteins were linked to biotin by incubating the blot at room temperature for 1 h in a solution of 0.1 M NaHC03, pH 8.4, containing N-hydroxysuccinimidobiotin (Sigma) 1 pg/ml. The blot was washed thrice with PBS and incubated for 30 rnin at room temperature with peroxidase-conjugated streptavidin (BRL) diluted in PBS containing BSA 3% w/v. After three washes, the blot was soaked in a solution of o-dianisidine prepared as described by Towbin et al. (1979) .
Dot-enzyme immunoassay
A dot-enzyme immunoassay was used for rapid screening of several monoclonal antibodies against a large number of H. infuenzae strains. The bacterial strains were grown overnight on chocolate-agar plates and an inoculum of c. lo9 bacteria/ml was prepared in PBS. A small amount of the suspension, 5 pl, was applied to a nitrocellulose paper and allowed to dry at room temperature. The nitrocellulose paper was soaked in PBS solution containing BSA 3% w/v for 30 rnin to block nonspecific protein binding sites, and then incubated for 1 h at 37°C with mouse hyperimmune sera or ascitic fluids diluted 1 in 100 in PBS containing BSA 3% w/v. The sheet was washed thrice with PBS and incubated with peroxidase-conjugated goat anti-mouse immunoglobulins (Cappel, Cochranville, PA, USA) diluted 1 in 1000 in PBS containing BSA 3% w/v. After incubation for 1 h at 37°C and three washes, the blots were soaked in a solution of o-dianisidine.
Absorption of monoclonal antibody
Dilutions of hybridoma supernates (0.5 ml) were mixed with lo9 live intact H. infruenzae cells kept in the cold. The suspensions were incubated twice with fresh H. infuenzae cell suspensions for 2 h at 4°C and then centrifuged. The resulting supernates were tested for antibody activity by ELISA. Viable counts of bacteria before and after the absorption reflected no loss of viability.
Enzymatic treatment of OMPs
For protein digestion, 25 pg of proteinase K (Boehringer Mannheim GmbH, West Germany) or 150pg of protease from Streptomyces griseus type VI (Sigma) in PBS was added to 15 pl (protein 1 mg/ml) of outermembrane preparation of H. infuenzae type b strain. After incubation for 1 h at 37"C, the OMP concentration was adjusted to 2.5 pg/ml with 0.05 M carbonate buffer, pH 9.6, and 0.1 ml of the solution was dispensed into each well of a Linbro E.I.A. microtitration plate and allowed to adsorb for 60 min at 37°C. The reactivity of monoclonal antibodies with these treated outer-membrane antigens were tested by ELISA as described. The antibody-containing supernates tested against proteinase Kor protease-treated OMPs were collected and retested against untreated outer-membrane preparations as control for possible residual enzymatic activity against the monoclonal anti bodies.
Isolation of lipopolysaccharide (LPS)
LPS was isolated from H. infuenzae type b by a rapid phenol-water extraction procedure as described by Inzana (1983) .
Bactericidal assay
The bactericidal activity of the ascitic fluids was estimated as described by Brodeur et al. (1985) . Dilutions of the ascitic fluid were made in PBS containing 0.15 mM CaCl,, 0.5rnM MgC1, and BSA O.l%w/v. A sample (100 pl) of micro-organisms (5 x 103/ml) was added to each mixture of loop1 of dilution of ascitic fluid and 200 pl of guinea pig serum as a source of complement. The mixtures were kept at 37°C for 45 min and then 100 pl of each mixture was plated on chocolate agar. The plates were incubated overnight at 37°C. The dilution giving 50% killing was considered to be the bactericidal titre.
Results
Outer-membrane protein profiles of H . injluenzae
We examined the polypeptide composition of the outer membrane of several clinical isolates of H . injluenzae type b by SDS-PAGE. OMPs were extracted by the lithium chloride procedure which did not require sonication or treatment with detergent. All type-b strains had a similar protein profile and each strain contained major OMPs with apparent mol. wts (lo3) of 43, 39, 37 and 27. In some strains, the proteins of mol. wt (lo3) 39 and 37 were each resolved into two polypeptides. The presence of the 39 x 103-mol. wt band was vaguely discernible in some strains ( fig. 1, lanes 7, 9, 11 ) and not detectable in the strain represented by lane 12 or the untypable strain in lane 4. The preparation of outer membranes of H . inzuenzae type b strain 3068 (fig. 1, lane 8) was selected as the immunogen for hybridisation because all the major OMPs had been demonstrated by SDS-PAGE in this preparation.
Properties of monoclonal antibodies
More than 340 hybrid clones were obtained by fusing sensitised spleen cells with SP2/0 plasmacytoma cells. The screening for monoclonal antibodies in hybridoma culture supernates was performed by ELISA, with H . inzuenzae type b strain 3068 outermembrane preparations as coating antigens. Each positive hybrid clone supernate was further tested against several type b and untypable H. inpuenzae strains by dot-enzyme immunoassay and against the OMPs by ELISA and Western blotting. Ten hybridoma cell lines showing different patterns of reactivity were obtained (table I). Mabs Hb-1, Hb-2 and Hb-5 reacted specifically with H . inzuenzae type b whereas Mabs HI-3, HI-7, HI-8, HI-9 and HI-10 cross-reacted with type b and untypable strains. Mabs HI-4 and HI-6 were specific to the type b strains but did not cross-react with all of the 15 different strains tested. Hybridomas producing antibodies directed against outer-membrane preparations of H . inzuenzae were subcloned twice by limiting dilution and the class and subclass of these immunoglobulins were determined by gel immunodiffusion. One Mab, HI-3 was an IgM, whereas all other Mabs were IgGs. # Bacterial strains were tested either by ELISA or in a dotenzyme immunoassay.
Monoclonal antibody reactivity with proteolytic enzyme-treafed OMPs
Outer-membrane preparation of H . incfluenzae type b strain 3068 was incubated with proteinase K or protease before being used as coating antigen in an ELISA assay. These treatments altered the OMP structures such that the monoclonal antibody reactivities in the ELISA assay could not be detected. When these antibodies were retested against non-treated OMPs, the absorbance values were positive (table 11) thus showing that the antibodies were not affected by the enzyme treatments. Similar resu'tts were obtained after either proteinase-K or protease treatment with anti-OMP monoclonal antibodies. A human monoclonal antibody designated HiH2 was used as a control because it is directed against a LPS of H . incfluenzae type b (unpublished observations) which is present in the outer-membrane preparations. When tested against proteinase K-or protease-treated OMPs, Mab HiH2 stilI demonstrated activity. t After 1 hr at 37"C, the supernate from wells coated with proteinase K-treated OMPs was transferred to wells coated with non-treated OMPs. $ HiH2 is a human Mab directed against a LPS epitope. Q The OMPs were treated with protease. fig. 2D ). Six of the 10 monoclonal antibodies reacted with OMPs transferred from the SDS-PAGE to nitrocellulose sheets. Three different OMPs with apparent mol. wts (lo3) of 43, 37 and 13 were recognised by these antibodies (table I) . The serotype-specific Mabs Hb-1 and Hb-2 recognised an epitope on the 37 x 103-mol. wt OMP ( fig.  2B and C) . A competition binding assay with I2'Ilabelled Hb-2 demonstrated that Mabs Hb-1 and Hb-2 were directed against the same epitope or closely-related epitopes present on the 37 x lo3mol. wt OMP (data not shown). SP2/0 mouse myeloma cell-induced ascitic fluids or SP2/0 culture supernates gave negative results in immunoblots.
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Reactivity of monoclonal antibodies with LPS Mabs Hb-1 and Hb-2 were tested against outermembrane preparation of LPS of H . inzuenzae type b by a dot-enzyme immunoassay. Mabs Hb-1 and Hb-2 reacted with the outer-membrane preparation but not with LPS ( fig. 3) . Human Mab HiH2 directed against LPS and mouse hyperimmune sera were used as positive controls.
Binding properties of Mab Hb-2
To determine whether Mab Hb-2 was directed against a cell surface-exposed epitope of the 37 x 103-m01. wt OMP, dilutions of hybridoma culture supernate were incubated with intact H . inzuenzae cells. The supernates were then tested by ELISA for reactivity with outer-membrane preparation and compared with unabsorbed controls. The absorption of Hb-2 with H . inJluenzae type b strain resulted in complete removal of the antibody (table  111) . Hb-2 supernates absorbed with untypable H . inzuenzae strain gave results similar to the nonabsorbed supernates. Bactericidal assay also suggested that Hb-2 was directed against a cell surface-exposed antigenic determinant. The bactericidal titre of Hb-2 ascitic fluid was >500 whereas control SP2/0 mouse myeloma-induced normal ascitic fluid showed no bactericidal activity.
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SpeciJicity of Mab Hb-2
Initial characterisation by ELISA showed that Hb-2 reacted only with H . influenzae type b strains. A dot-enzyme immunoassay was used for rapid screening of this antibody against numerous bacterial strains. Mab Hb-2 reacted specifically with 326 strains of H . incfluenzae type b, but not with H . inzuenzae strains of other serotypes (a, c-f, 12 strains) or any untypable strains (86 strains). Mab Hb-2 also showed no cross-reactivity with H . parainzuenzae (6 strains), Escherichia coli (1 2 strains), Neisseria meningitidis (22 strains), Streptococcus group B (20 strains) or Str. pneumoniae (30 strains).
Discussion
Many methods of preparation of outer membranes have been described (Johnston et al., 1976; McDade and Johnston, 1980; Loeb et al., 1981; Barenkamp et al., 1981b; Coulton and Wan, 1983; Van Alphen et al., 1983) . The procedure for obtaining partially-purified OMPs described by Johnston et al. (1976) has the advantage of eliminating the sonication procedure or treatment with detergents, thus preventing the breakage of the bacterial cell wall and avoiding contamination of the preparation with cytoplasmic components. This was confirmed by the observation of intact spheroplasts by electronmicroscopy. The protein patterns obtained with outer membrane extracted by the lithium chloride method closely resembled those of H . injluenzae outer membrane isolated by isopycnic sucrose gradient centrifugation (Stull et al., 1985) . All strains of H . inzuenzae type b had SDS-PAGE patterns of OMPs similar to those of other gram-negative bacteria (Costerton et al., 1974; Heckels, 1981 ; Tsai et al., 1981 ; Brodeur et al., 1985) . Furthermore, when these OMPs were used to produce hyperimmune sera in mice, 11 bands were detected by immunoblotting, labelling with 251-labelled anti-mouse immunoglobulins and autoradiography. Examination of the protein patterns confirmed the variability of the proteins of mol. wts (lo3) 39 and 38 (Loeb and Smith, 1980; Gulig et al., 1983) . These proteins were present in varying quantities in related strains and were undetectable in other strains. The 37 x 103-mol. wt protein was present in all strains and sometimes appeared as two proteins of similar mol. wt.
Analysis of the antigenic composition of the OMPs of H. inzuenzae type b has been encouraged by recent works which demonstrated that monoclonal antibodies directed against specific OMPs of gram-negative bacteria can protect against systemic infections in animals (Wang and Frasch, 1984; Brodeur et al., 1985; Kimura et al., 1985) . A monoclonal antibody reacting with an accessible surface-exposed epitope present on all H. influenzae type b strains would be useful for the development of a diagnostic test for H . influenzae type b infections or for the indentification of common antigenic determinants for the development of an OMP against a 1OOx 103-mol. wt protein (Gulig et al., 1984) . Recently, an antibody reacting with a 98 x 103-mol. wt protein recognised 83 of the 120 H . inzuenzae type b strains tested (Kimura et al., 1985) . Mab Hb-2 reacted with all 326 strains of H . injfuenzae type b tested in a dot-enzyme immunoassay. Binding assays as well as bactericidal data demonstrated that Mab Hb-2 recognised a cell surface-exposed antigenic determinant. Western immunoblotting followed by autoradiography revealed that the Mab Hb-2 reacted specifically with a 37 x 103-mol. wt protein common to all H . influenzae type b strains tested. The enzymatic treatment of OMPs with proteinase K and protease suggested that the antibody was directed against a protein antigenic determinant. Furthermore, Mab Hb-2 failed to react with a preparation of LPS and with strains of other bacterial species. This is the first report of a single murine monoclonal antibody, directed against an OMP, which recognises a cell surface-exposed antigenic determinant on H. influenzae type b strains. The usefulness of Mab Hb-2 in immunodiagnostic procedures for the detection of microbial antigens in clinical specimens has already been evaluated (Belnaaza et al., 1986) . Furthermore, an experimental model of infection has been developed and will be used to evaluate the immunoprotective potential of Mab Hb-2.
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